Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX and UOW to Collaborate

Published: Friday, September 21, 2012
Last Updated: Friday, September 21, 2012
Bookmark and Share
A research partnership between AB SCIEX and the University of Wollongong will develop lipid analysis capabilities, including the most definitive and comprehensive identification of double bond position in lipids.

This collaboration is part of AB SCIEX’s new Academic Partnership Program, which helps support academic researchers to push the limits of biomedical research.

The agreement provides AB SCIEX, a global leader in life science analytical technologies, with an exclusive license to University of Wollongong’s (UOW’s) “OzID” intellectual property, a patented technology which allows scientists to understand lipid structure faster and with better granularity than currently available alternatives.

Funded by an ARC Linkage Project grant, the research plan will see a multi-disciplinary UOW research team working with AB SCIEX to develop a standardized procedure for determining double bond position in lipids. This will include exploring lipid functions within the human body, such as energy storage, cell membrane structure and hormone signaling.

“Altered lipid metabolism has been linked to such global health concerns as obesity, type 2 diabetes, cardiovascular disease and various cancers,” explained Principal Investigator, Dr Todd Mitchell from UOW’s School of Health Sciences. “Recent advances in mass spectrometry have spawned the field of lipidomics which, together with proteomics, metabolomics and genomics, focuses on the systematic study of complex interactions in biological systems.”

"Ozone induced dissociation, or OzID, first harnesses the power of mass spectrometry to separate one lipid compound out of literally hundreds on the basis of mass, and then uses ozone like a pair of scissors to cut the molecule at a particular position, namely a double bond,” says Principal Investigator, Associate Professor Stephen Blanksby from UOW’s School of Chemistry. “This allows an unambiguous assignment of the compound structure and, importantly, differentiates molecules that vary only by the position of their double bonds.”

“Learning more about the molecular distribution of lipids in complex biological samples may provide a greater understanding of lipid metabolism, its role in health and disease, and potential ways to prevent or manage diseases," added Dr. Blanksby, who will be presenting results of his work with OzID at the IMSC conference this week.

Ron Bonner, Principal Scientist at AB SCIEX and sponsor of the AB SCIEX Academic Partnership Program, said, “Lipid research is a fast-growing area in need of new breakthroughs to advance the impact that lipidomics can have on biological studies. We see a great opportunity of applying cutting-edge intellectual property by working with the forward-thinking researchers at the University of Wollongong to take innovative ideas such as OzID from the idea phase to market. This is the benefit of academics working with industry leaders such as AB SCIEX.”

AB SCIEX is partnering with academic researchers, including up-and-coming scientists, to lower the barriers to advancements and breakthroughs in medicine and the advanced study of biology. The new wave of biological studies known as “network biology” and the -omics fields require advanced scientific techniques and powerful technologies. The Academic Partnership Program is designed to provide access to technical expertise and support in mass spectrometry and chromatography.

The agreement was facilitated with the assistance of UniQuest Pty Limited, UniQuest Managing Director, David Henderson, said the license agreement highlighted the growing interest from international companies in the work of Australian university researchers addressing global health issues.

“Protecting the intellectual property and securing US patents helped to boost the value of the OzID technology for industry partners like AB SCIEX,” Henderson said. “This joint development project is likely to draw more attention to the way Australian lab-based discoveries impact positively on emerging fields of science as well as translate into a better understanding of health and disease.”

The OzID research was published in the Journal of The American Society for Mass Spectrometry. Patents were granted by the United States Patent and Trademark Office in 2010 and 2012.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
Dr. Gyula Vigh wins Arnold O. Beckman Award
SCIEX sponsored award recognizes outstanding contributions to the field of electrodriven separation techniques.
Thursday, May 07, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
SCIEX Announces OneOmics™ Collaborators
Advaita Bioinformatics, Researchers at Yale University and ISB launch applications and libraries that combine next-generation proteomics and next-generation sequencing data in innovative ways.
Thursday, March 19, 2015
SCIEX and Labor Berlin Collaboration to Advance Forensic Testing
Collaboration for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library.
Thursday, March 05, 2015
New Capabilities for Bioanalysis Studies at the International Pharmaceutical Research Center
AB SCIEX Triple Quad™ 6500 LC/MS/MS systems enable new levels of sensitivity for clinical trials of inhaled drugs.
Wednesday, February 11, 2015
Improved Accuracy of Pesticide Detection in Food
European Reference Laboratory improves accuracy of pesticide detection in food with AB SCIEX mass spectrometry instrumentation.
Wednesday, February 04, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Scientist Wins HUPO 2014 Science and Technology Award
Winner becomes second team member to be recognized for the commercialization of transformative chemistries such as iTRAQ® eagents.
Monday, October 06, 2014
AB SCIEX, Illumina Collaborate to Create Multi-omics Cloud-Computing Environment
Integration of SWATH™ Apps with BaseSpace® brings next-generation proteomics and next-generation sequencing together for the first time.
Thursday, October 02, 2014
AB SCIEX and Dalton Collaborate to Advance ADC Analysis
Collaboration supports movement to develop targeted anti-body based therapies.
Friday, August 29, 2014
AB SCIEX, Dalton Pharma Services Announce ADC Partnership
Research collaboration aims to develop Antibody-Drug Conjugate analysis capabilities.
Wednesday, August 27, 2014
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!